Position in MYGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$676,089
-$726,141 QoQ
Shares Held
150,242
-34.1% QoQ
Ownership
0.159%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 15%
Shared 0%
None 85%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026IEQ CAPITAL, LLC holds $213,776,491 across 18 Diagnostics & Research names. MYGN ranks #11 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
348,916 | $43,007,386 | |
| 2 | DHR |
Danaher Corp /De/
|
213,543 | $40,487,752 | |
| 3 | NTRA |
Natera, Inc.
|
192,810 | $38,560,071 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
66,044 | $31,713,668 | |
| 5 | A |
Agilent Technologies, Inc.
|
224,722 | $25,613,813 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
96,067 | $16,383,266 | |
| 7 | TMO |
Thermo Fisher Scientific Inc.
|
16,409 | $8,065,515 | |
| 8 | LH |
Labcorp Holdings Inc.
|
14,019 | $3,740,409 |
All Filings in MYGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $676,089 | 150,242 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,402,230 | 228,005 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,167,890 | 161,534 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $405,004 | 76,272 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $158,116 | 17,826 | Shares | Other | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||